References
- P. A. Bottomley, “Human in vivo NMR spectroscopy in diagnostic medicine: Clinical tool or research probe?,” Radiology, Vol. 170, No. 1, pp. 1-5, 1989. https://doi.org/10.1148/radiology.170.1.2642336
- B. Ross, R. Kreis, T. Ernst, “Clinical tools for the 90s: magnetic resonance spectroscopy and metabolite imaging,” European journal of radiology, Vol. 14, No. 2, pp. 128-140, 1992. https://doi.org/10.1016/0720-048X(92)90226-Y
- M. W. Weiner, “The promise of magnetic resonance spectroscopy for medical diagnosis,” Investigative radiology, Vol. 23, No. 4, pp. 253-261, 1988. https://doi.org/10.1097/00004424-198804000-00003
- N. H. Koo, H. B. Lee, K. W. Choi, S. Y. Son, B. K. Yoo, “The Study on Signal to Noise Ratio of Single-Shot Turbo Spin Echo to Reduce Image Distortion in Brain Stem Diffusion MRI,” Journal of the Korean Society of Radiology, Vol. 10, No. 4, pp. 241-246, 2016. https://doi.org/10.7742/jksr.2016.10.4.241
- P. B. Barker, D. O. Hearshen, M. D. Boska, "Singlevoxel proton MRS of the human brain at 1.5 T and 3.0 T. Magnetic resonance in medicine," v.45, no.5, pp. 765-769, 2001. https://doi.org/10.1002/mrm.1104
- K. H. Chang, I. C. Song, "Comparison of Proton T1 and T2 Relaxation Times of Cerebral Metabolites between 1.5 T and 3.0 T MRI using a Phantom," Journal of the Korean Society of Magnetic Resonance in Medicine, Vol. 12, No. 1, pp. 20-26, 2008.
- T. Ethofer, I. Mader, U. Seeger, G. Helms, M. Erb, W. Grodd, A. Ludolph, U. Klose, “Comparison of longitudinal metabolite relaxation times in different regions of the human brain at 1.5 and 3 Tesla,” Magnetic resonance in medicine, Vol. 50, No. 6, pp. 1296-1301, 2003. https://doi.org/10.1002/mrm.10640
- K. Farahani, U. Sinha, S. Sinha, L. C. Chiu, R. B. Lufkin, “Effect of field strength on susceptibility artifacts in magnetic resonance imaging,” Computerized Medical Imaging and Graphics, Vol. 14, No. 6, pp. 409-413, 1990. https://doi.org/10.1016/0895-6111(90)90040-I
- G. Starckab, M. Ljungberg, B. Vikhoff-Baaz, M. Alpsten, S. Ekholm, E. Forssell-Aronsson, “Point-wise measurements of MRS volume selection performance are insensitive to magnetic susceptibility effects of phantom materials,” Magnetic resonance imaging, Vol. 18, No. 7, pp. 867-874, 2000. https://doi.org/10.1016/S0730-725X(00)00184-3
- W. Shin, E. Gang, S. Chun, “Quantitative Analysis of Brain Metabolite Spectrum Depending on the Concentration of the Contrast Media in Phantom,” Journal of the Korean Society of Radiology, Vol. 9, No. 1, pp. 47-53, 2015. https://doi.org/10.7742/jksr.2015.9.1.47
- K. W. Choi, S. M. Seo, S. Y. Son, "Evaluation of the signal intensity of magnetic resonance angiography in accordance with the dilution rate of the contrast agent," Journal of the Korea Academia-Industrial cooperation Society, Vol. 15, No. 8, pp.5 124-5130, 2014. https://doi.org/10.5762/KAIS.2014.15.8.5124
- R. Katz-Brull, P. T. Lavin, R. E. Lenkinski, “Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions,” Journal of the National Cancer Institute, Vol. 94, No. 16, pp. 1197-1203, 2002. https://doi.org/10.1093/jnci/94.16.1197
- S. J. Eun, J. J. Kim, S. C. Yoo, "A Study on the Metabolite Changes in Brain Diseases: 3 Teslar 1H Magnetic Resonance Spectroscopy," Journal of the Korean Society of Radiology, Vol. 8, No. 1, pp. 35-42, 2014. https://doi.org/10.7742/jksr.2014.8.1.35
- R. Kreis, T. Ernst, B. D. Ross, “Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy,” Magnetic Resonance in Medicine, Vol. 30, No. 4, pp. 424-437, 1993. https://doi.org/10.1002/mrm.1910300405
- P. J. Bore, “The role of magnetic resonance spectroscopy in clinical medicine,” Magnetic resonance imaging, Vol. 3, No. 4, pp. 407-413, 1985. https://doi.org/10.1016/0730-725X(85)90405-9
- O. Henriksen, “MR spectroscopy in clinical research,” Acta Radiologica, Vol. 35, No. 2, pp. 96-116, 1994. https://doi.org/10.1177/028418519403500202
- E. H. Goo, “Usefulness of the PRESS Technique using 3.0 T Magnetic Resonance Spectroscopy for Evaluation of Non-Alcoholic Fatty Liver Disease Patients,” Journal of the Korea Academia-Industrial cooperation Society, Vol. 13, No. 12, pp. 5931-5936, 2012. https://doi.org/10.5762/KAIS.2012.13.12.5931
- C. H. Suh, S. G. Cho, M. K. Lim, M. Y. Kim, K. H. Lee, H. J. Kim, “Proton MR Spectroscopic Features According to Change of Hepatic Parenchymal Iron Content after SPIO Injection,” Journal of the Korean Radiological Society, Vol. 45, No. 3, pp. 277-284, 2001. https://doi.org/10.3348/jkrs.2001.45.3.277
- M. H. Kim, J. U. Choi, J. W. Oh, "The Study of Approprite Time for Spectroscopy Recording According to the Effect of Contrast Agent in Breast Ductal Carcinoma Patients," Journal of the Korean Society of Radiology, Vol. 22, No. 1, p. 29, 2012.
- C. Loos, E. Achten, P. Santens, “Proton magnetic resonance spectroscopy in Alzheimer's disease, a review,” Acta neurologica Belgica, Vol. 110, No. 4, pp. 291-298, 2010.